Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study ID
- NCT00004139
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- docetaxel — DRUG
- gemcitabine hydrochloride — DRUG
- irinotecan hydrochloride — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to compare the effectiveness of gemcitabine plus either docetaxel or irinotecan in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Key Dates
- Start date
- Sep 30, 1999
- Status verified
- Jul 2016
- Primary completion
- Jul 31, 2004
- Completion
- Jan 31, 2006
Study Design
- Enrollment
- 80 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Gemcitabine + Irinotecan
- Experimental: Gemcitabine + Docetaxel
Primary Outcome Measure
response rate [ Time Frame: Up to 2 years ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vincent T. Lombardi Cancer Research Center, Georgetown University | Washington D.C. | District of Columbia | 20007 | - |
| Walter Reed Army Medical Center | Washington D.C. | District of Columbia | 20307-5000 | - |
| Barnes-Jewish Hospital | St Louis | Missouri | 63110 | - |
| CCOP - Southern Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | - |
| Duke Comprehensive Cancer Center | Durham | North Carolina | 27710 | - |
| Medical University of South Carolina | Charleston | South Carolina | 29425-0721 | - |
| CCOP - Greenville | Greenville | South Carolina | 29615 | - |
| University of Tennessee, Memphis Cancer Center | Memphis | Tennessee | 38163 | - |
Find similar trials in Washington D.C., DC
By condition
By specialty
By research site
Vincent T. Lombardi Cancer Research Center, Georgetown University· Washington D.C., DCWalter Reed Army Medical Center· Washington D.C., DCBarnes-Jewish Hospital· St Louis, MOCCOP - Southern Nevada Cancer Research Foundation· Las Vegas, NVDuke Comprehensive Cancer Center· Durham, NCMedical University of South Carolina· Charleston, SC
Related Studies
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruiting · Vanderbilt-Ingram Cancer Center · Nashville, Tennessee
- Molecular Predictors of Cancer in Patients at High Risk of Lung CancerRecruiting · Vanderbilt-Ingram Cancer Center · Nashville, Tennessee
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California